EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Third Harmonic Bio's enterprise value is $314.85 Mil.
Third Harmonic Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil. Therefore, Third Harmonic Bio's EV-to-Revenue for today is .
The historical rank and industry rank for Third Harmonic Bio's EV-to-Revenue or its related term are showing as below:
THRD's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.205 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for Third Harmonic Bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Third Harmonic Bio's EV-to-Revenue
For the Biotechnology subindustry, Third Harmonic Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Third Harmonic Bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Third Harmonic Bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Third Harmonic Bio's EV-to-Revenue falls into.
Third Harmonic Bio's current Enterprise Value is $314.85 Mil.
Third Harmonic Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Third Harmonic Bio (NAS:THRD) EV-to-Revenue Explanation
Third Harmonic Bio's share price for today is $13.865.
Third Harmonic Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Third Harmonic Bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Third Harmonic Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Third Harmonic Bio (Third Harmonic Bio) Business Description
Third Harmonic Bio Inc is a clinical-stage company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases.. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
THRD has been successfully added to your 